Townsend & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-16,338
Closed -$1.4M 72
2020
Q4
$1.4M Sell
16,338
-1,150
-7% -$95.1K 1.02% 44
2020
Q3
$1.4M Sell
17,488
-9,446
-35% -$720K 1.09% 49
2020
Q2
$1.97M Sell
26,934
-3,662
-12% -$260K 1.66% 11
2020
Q1
$2.11M Sell
30,596
-559
-2% -$39.4K 2.2% 5
2019
Q4
$2.16M Buy
+31,155
New +$2.12M 1.89% 11

Other funds holding CL

Townsend & Associates's CL Position: Q1 2021 in Review

Townsend & Associates sold out of Colgate-Palmolive (CL) in Q1 2021, closing a stake of 16,338 shares — an estimated $1.4M sold.

Townsend & Associates first reported a position in CL in Q4 2019 and held it in 5 quarters. The position peaked at $2.16M in Q4 2019. 1,607 funds tracked by Wall St. Rank hold CL as of Q1 2021.

  • Townsend & Associates reported no remaining Colgate-Palmolive position as of Q1 2021 after selling out during the quarter.
  • Townsend & Associates sold 16,338 Colgate-Palmolive shares in Q1 2021, an estimated $1.4M.
  • Townsend & Associates first reported a position in Colgate-Palmolive in Q4 2019 and held it in 5 quarters.
  • Townsend & Associates's Colgate-Palmolive position peaked at $2.16M in Q4 2019.
  • 1,607 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2021.

Based on Townsend & Associates's 13F filing for Q1 2021, filed 15 Apr 2021.